BL1107 Response and Intensity Guided Dosing for Hyperemia Resolution Trial

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
Trial RX01-BL1107-1202 is designed to identify the lowest effective concentration of BL1107 required for complete resolution of conjunctival hyperemia in participants with DED. Participants will be masked to concentration of BL1107 received.
Epistemonikos ID: b948ff9ef408cce3bdc137e1cb6b91b17e44d88f
First added on: Aug 21, 2026